Registry and Biorepository for IBD in Central Texas

Part of paid clinical trials in Austin, Texas.

Sponsor
University of Texas at Austin
Study ID
NCT04617184
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • NO INTERVENTION — OTHER
    THERE IS NO INTERVENTION TO THIS TRIAL. THIS IS A REGISTRY

Study Details

This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.

Key Dates

Start date
Jun 1, 2021
Status verified
May 2021
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Inflammatory Bowel Disease
    any patient with IBD will be included in the registry

Primary Outcome Measure

Number of patients with inflammatory bowel disease [ Time Frame: 10 YEARS ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Dell Medical School, UT AustinAustinTexas78712
Banjamin Chebaa, BA
[email protected]
512-495-5641

Find similar trials in Austin, TX

By condition
Crohn's diseaseUlcerative colitis
By specialty
GastroenterologyInflammatory bowel diseaseAutoimmune disease
By research site
Dell Medical School, UT Austin· Austin, TX

Related Studies